Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-250-8 | CAS number: 6197-30-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August/September 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Octocrilene
- EC Number:
- 228-250-8
- EC Name:
- Octocrilene
- Cas Number:
- 6197-30-4
- Molecular formula:
- C24H27NO2
- IUPAC Name:
- 2-ethylhexyl 2-cyano-3,3-diphenylacrylate
- Details on test material:
- - Name of test material (as cited in study report): Uvinul N 539
- Physical state: light yellowish, liquid/oily
- Analytical purity: 98.3%
- Purity test date: 1992-11-03
- Lot/batch No.: 2070182 ( German version), 505396-70182 ( American version), date of receipt: September 1992
- Stability under test conditions: confirmed
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
male and female NMRI mice
- Source: Charles River GmbH, WIGA, Sulzfeld, FRG
- Age at study initiation: no data
- Weight at study initiation: Animals with a mean weight of about 26 .5 g were used for the study.
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: individually in Makrolon cages , type MI
- Diet (ad libitum): Standardized pelleted feed (Kliba Haltungsdiät, Klingentalmühle AG , Kaiseraugst, Switzerland)
- Water (ad libitum): drinking water from bottles
- Acclimation period: about 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: olive oil (test substance); water (positive control substances)
No further data - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Substance formulations were prepared immediately before administration. The concentrations of the test solutions were adjusted to 20 g/100 ml, 10g/100 ml, and 5 g/100 ml for the groups receiving 2000, 1000, and 500 mg/kg bw, respectively - Duration of treatment / exposure:
- single dose
- Frequency of treatment:
- single dose
- Post exposure period:
- sacrifice at 16, 24 and 48 hours after dosing (2000 mg/kg bw)
sacrifice at 24 hours after dosing (other dose groups)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000, 2000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5 males and 5 females per group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): experienced positive control substance for clastogenicity (chromosome-damaging effects)
- Route of administration: p.o.
- Doses / concentrations: 20 mg/kg bw; vehicle: distilled water
vincristine
- Justification for choice of positive control(s): experienced positive control substance for aneugenicity (spindle poison effects)
- Route of administration: i.p.
- Doses / concentrations: 0.15 mg/kg bw; vehicle: distilled water
Examinations
- Tissues and cell types examined:
- bone marrow cells (polychromatic and normachromatic erythrocytes)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In a pretest for the determination of the acute oral toxicity the amount of 2000 mg/kg body weight recommended as the highest dose according to the EEC Directive 84/449, B 12, or according to the OECD Guideline No. 474 was survived by all animals. As signs of toxicity only piloerection was observed about 4-5 hours.
Therefore , a dose of 2000 mg/kg body weight was selected as the highest dose in the present cytogenetic study. 1000 mg/kg and 500 mg/kg body weight were administered as further doses.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
See table below (Additional remarks)
DETAILS OF SLIDE PREPARATION:
The bone marrow was prepared according to the method described by SCHMID, W.
- The two femora were prepared from the animals, and all soft tissues were removed.
- After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum which was at 37°C (about 2 ml / femur).
- The suspension was mixed thoroughly with a pipette, centrifuged at 1500 rpm for 5 minutes, the supernatant was removed except for a few drops, and the precipitate was resuspended.
- 1 drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges, the preparations were dried in the air and subsequently stained.
Staining:
The slides were stained in eosin and methylene blue solution for 5 minutes, rinsed in aqua dest. and then placed in fresh aqua dest . for 2 or 3 minutes. They were finally stained in Giemsa solution for 12 minutes. After being rinsed twice in aqua dest. and clarified in xylene, the preparations were embedded in Corbit-Balsam.
METHOD OF ANALYSIS:
Microscopic evaluation
In general, 1000 polychromatic erythrocytes from each of the male and female animals of every test group are evaluated and investigated for micronuclei. The normochromatic erythrocytes (= normocytes), which occur, are also scored. The following parameters are recorded:
- Number of polychromatic erythrocytes
- Number of polychromatic erythrocytes containing micronuclei
- Number of normochromatic erythrocytes
- Number of normochromatic erythrocytes containing micronuclei
- Ratio of polychromatic to normochromatic erythrocytes
- Number of small micronuclei (d < D/4) and of large micronuclei (d > D/4) (d = diameter of micronucleus, D = cell diameter )
Slides were coded before microscopic analysis.
OTHER:
Clinical examinations
After the administration of the test substance the animals were examined for any evident clinical signs of toxicity. - Statistics:
- The statistical evaluation of the data was carried out using the program system MUKERN (BASF AG).
The number of micronuclei in polychromatic erythrocytes were analysed.
A comparison of the dose group with the vehicle control was carried out using the Wilcoxon-Test for the hypothesis of equal medians. Here , the relative frequencies of cell s with micronuclei of each animal were used. If the results of this test were significant, labels (* for p <= 0. 05 , ** for p< = 0.01) were set. This test was performed one-sided.
This analysis was done separately for each sex and combined for both sexes.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Clinical examinations
The single oral administration of the vehicle in a volume of 10 ml/kg body weight was tolerated by all animals without any signs or symptoms. Doses of 500 mg/kg , 1000 mg/kg or 2000 mg/kg body weight led to piloerection about 15 minutes after treatment which lasted for about 2 hours. Neither the single administration of the positive control substance cyclophosphamide in a dose of 20 mg/kg body weight nor that of vincristine in a dose of 0.15 mg/kg body weight caused any evident signs of toxicity.
Microscopic evaluation
Remark: The unit"per mille" used in the original study report has been converted to "per cent" in this freetext due to editorial reasons.
The single oral administration of olive oil in a volume of 10 ml/kg body weight led to 0.13% polychromatic erythrocytes containing micronuclei after the 24 -hour sacrifice interval. After the single administration of the highest dose of 2000 mg/kg body weight, 0.2% polychromatic erythrocytes containing micronuclei were found after 16 hours, 0.15% after 24 hours and 0.13% after 48 hours. In the two lower dose groups rates of micronuclei of about 0.19% (1000 mg/kg group) and 0.13% (500 mg/kg group) were detected after a sacrifice interval of 24 hours in each case.
With 1.54% the positive control substance cyclophosphamide for clastogenicity, as expected, led to a clear increase in the number of polychromatic erythrocytes containing mainly small micronuclei at a dose level of 20 mg/kg body weight.
With 6.04% the positive control vincristine for spindle poison effects also led to a clearly enhanced number of micronuclei containing polychromatic erythrocytes with the expected amount of large micronuclei, i.e. 1.48%.
The number of normochromatic erythrocytes (NCEs) containing micronuclei did not differ to any appreciable extent in the negative control or in the various dose groups at any of the sacrifice intervals. An amount of about 0.33% (p<0.05) in the highest dose group must be regarded as an incidental finding and cannot be related to the test substance treatment due to the short sacrifice interval of 24 hours at which the NCEs had already past the sensitive stage at the time of treatment. Furthermore, there is no corresponding finding in polychromatic erythrocytes. Thus, the test substance Uvinul N 538 did not lead to any increase in the rate of micronuclei.
The number of normochromatic or polychromatic erythrocytes containing small micronuclei (d<D/4) did not deviate from the solvent control value at any of the sacrifice intervals. Nor were large micronuclei (d>D/4) observed either in the negative control group or in the three dose groups. No inhibition of erythropoiesis induced by the treatment of mice with Uvinul N 539 was detected; the ratio of polychromatic to normochromatic erythrocytes was always in the same range as that of the control values in all dose groups.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.